✦ LIBER ✦

Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis

✍ Scribed by Abe, Masanori; Okada, Kazuyoshi; Maruyama, Takashi; Maruyama, Noriaki; Soma, Masayoshi; Matsumoto, Koichi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term effects of pioglitazone and me

✍ M. Roden; M. Laakso; D. Johns; M. Widel; R. Urquhart; C. Richardson; S. Mariz; M 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

The long-term effect of pioglitazone on

✍ Annette Mathisen; Cindy Rubin 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Long-term safety, efficacy and side-effe

✍ E. Chantelau; M. Spraul; I. Mühlhauser; R. Gause; M. Berger 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 678 KB

Long-term effects on lipids and lipoprot

✍ D. J. Betteridge; B. Vergès 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 135 KB

Target for Glycemic Control in Type 2 Di

✍ Takashi Uzu; Tsuguru Hatta; Naoko Deji; Tamani Izumiya; Hisami Ueda; Itsuko Miya 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

Serum Lp(α), insulin resistance, metabol

✍ R.S. Elkeles; J.R. Diamond; G. Salerno; C. Hughes; W. Richmond; V. Anyaoku 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 151 KB